Geri-Care Pharmaceuticals is recalling five specific types of Geri-Care brand over-the-counter Acetaminophen and Aspirin sold in large-count bottles. These products were sold online through various retailers including Amazon, Simply Medical, and others between early 2021 and August 2021. The recall was issued because the packaging is not child-resistant, which is a violation of the Poison Prevention Packaging Act and can lead to accidental ingestion.
The packaging of these drugs is not child-resistant, posing a serious risk of poisoning if the contents are swallowed by young children. While no injuries have been reported, the high concentration and quantity of tablets in these bottles increase the potential for severe harm if accessed by a child.
Consumers should immediately store the recalled products in a safe location out of sight and reach of children, and safely dispose of the recalled product as soon as is practicable. Contact Geri-Care Pharmaceuticals for a full refund or replacement over-the-counter drug product.
Recalled Geri-Care Brand Extra Strength Acetaminophen 500mg tablets 1,000-count bottle
Recalled Geri-Care Brand Regular Strength Enteric Coated Aspirin 325mg tablets 250-count bottle
Recalled Geri-Care Brand Regular Strength Enteric Coated Aspirin 325mg tablets 1,000-count bottle
Recalled Geri-Care Brand Adult Low Dose Enteric Coated Aspirin 81mg tablets 300-count bottle
Recalled Geri-Care Brand Adult Low Dose Enteric Coated Aspirin 81mg tablets 1,000-count bottle
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response